Financials Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-07-15 pm EDT 5-day change 1st Jan Change
1.38 USD +123.30% Intraday chart for Autonomix Medical, Inc. +159.40% 0.00%

Valuation

Fiscal Period: March 2024
Capitalization 1 56.81
Enterprise Value (EV) 1 49.2
P/E ratio -2.86 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -6,655,418 x
EV / FCF -11,529,481 x
FCF Yield -0%
Price to Book 7.46 x
Nbr of stocks (in thousands) 18,811
Reference price 2 3.020
Announcement Date 5/31/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023 2024
Net sales - - -
EBITDA - - -7.393
EBIT 1 -13.59 -1.99 -7.474
Operating Margin - - -
Earnings before Tax (EBT) 1 -13.33 -1.99 -15.43
Net income 1 -13.33 -1.99 -15.43
Net margin - - -
EPS 2 -6.197 -0.1656 -1.055
Free Cash Flow - -1.108 -4.268
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 7/7/23 7/7/23 5/31/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023 2024
Net Debt 1 - - -
Net Cash position 1 2.04 0.86 7.61
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -1.11 -4.27
ROE (net income / shareholders' equity) - -153% -373%
ROA (Net income/ Total Assets) - -85.3% -91%
Assets 1 - 2.334 16.96
Book Value Per Share 2 0.9500 0.0500 0.4000
Cash Flow per Share 2 0.9900 0.0700 0.4600
Capex - - 0.02
Capex / Sales - - -
Announcement Date 7/7/23 7/7/23 5/31/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. Financials Autonomix Medical, Inc.